Ray Kaczmarek—the former CEO of Genezen—is an expert in gene therapy manufacturing with decades of experience leading operations, technology, and commercial supply strategies at pharmaceutical and biotech companies, Nanoscope said.
Samuel Barone, M.D., is a former Federal Drug Administration official and leader in the pharmaceutical space.
Left: LinedanceAI co-founder Mohamed Elwazer; Center illustration: leonello/iStock; Right: Lantern Pharma CEO Panna Sharma
Dallas-Fort Worth is well known for its tech expertise. Now it being recognized as the place where technology meets life science—a convergence that’s driving rapid growth in the biotech ecosystem. Leaders in the industry attribute this success to the unique convergence of the region’s exceptional tech talent pool and cutting-edge developments in life science....
Nanoscope Therapeutics Inc., a Dallas-based clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, has appointed Massoud Motamed, Ph.D., as vice president of quality.
Motamed brings nearly a decade of CGMP quality and compliance experience, including extensive experience in manufacturing and regulatory review of gene therapy products....